The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2173378
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP08779855.9
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
27/06/2008
Grant date:
19/03/2014
EP Publication Date:
19/03/2014
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
19/03/2014
EP B1 Publication Date:
19/03/2014
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
16/05/2014
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
26/06/2028
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
21/06/2016
Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
From:
21/06/2016
Name:
The United States Of America,As Represented By The Secretary, Department Of Health And Human Services
Address:
Office Of Technology Transfer National Institute Of Health 6011 Executive Boulevard Suite 325 MSC 7660, BETHESDA, MD 20892-7660, United States of America (US)
Historical Applicant/holder
From:
19/03/2014
To:
21/06/2016
Name:
Admune Therapeutics LLC
Address:
107 Water Street, DANVERS, MA 01923, United States of America (US)
From:
19/03/2014
To:
21/06/2016
Name:
The United States Of America,As Represented By The Secretary, Department Of Health And Human Services
Address:
Office Of Technology Transfer National Institute Of Health 6011 Executive Boulevard Suite 325 MSC 7660, BETHESDA, MD 20892-7660, United States of America (US)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
18/12/2015
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
Bulletin Heading:
EP2
Journal edition number:
2014/13
Publication date:
26/03/2014
Description:
European patents granted for the Netherlands
European Patent Bulletin
Issue number:
201412
Publication date:
19/03/2014
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC201601831A
Date Registered:
21/06/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
1
Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
2
Name:
The United States Of America,As Represented By The Secretary, Department Of Health And Human Services
Address:
Office Of Technology Transfer National Institute Of Health 6011 Executive Boulevard Suite 325 MSC 7660, BETHESDA, MD 20892-7660, United States of America (US)